enGene Inc.

NASDAQ: ENGN · Real-Time Price · USD
3.70
0.09 (2.49%)
At close: Aug 15, 2025, 3:59 PM
3.68
-0.54%
After-hours: Aug 15, 2025, 04:10 PM EDT

enGene Balance Sheet Statement

Financials in USD. Fiscal year is November - October.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Oct 31, 2024 Oct 31, 2023 Oct 31, 2022 Oct 31, 2021
Cash & Equivalents
173M 81.52M 20.43M 11.02M
Short-Term Investments
65.33M 76K n/a n/a
Long-Term Investments
59.53M 70K 131.53M 129.67M
Other Long-Term Assets
1.37M 860K -130.59M -128.73M
Receivables
332K 2.34M 1.34M 1.62M
Inventory
n/a n/a 74K 81K
Other Current Assets
8.7M 1.58M 739K 797K
Total Current Assets
247.36M 85.44M 22.58M 13.52M
Property-Plant & Equipment
2.91M 589K 387K 571K
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
63.81M 1.52M 1.33M 1.51M
Total Assets
311.17M 86.96M 23.91M 15.03M
Account Payables
1.41M 1.16M 723K 1M
Deferred Revenue
n/a n/a n/a 1.08M
Short-Term Debt
699K 562K 1.26M 1.05M
Other Current Liabilities
9.08M 2.69M 676K 850K
Total Current Liabilities
14.66M 5.26M 5.1M 3.22M
Long-Term Debt
22.47M 9.22M 30.84M 3.05M
Other Long-Term Liabilities
1.43M n/a 64.57M 62.21M
Total Long-Term Liabilities
23.9M 9.22M 95.42M 65.25M
Total Liabilities
38.56M 14.47M 100.52M 68.47M
Total Debt
25.02M 9.78M 32.11M 4.16M
Common Stock
509.81M 259.37M 16.39M 16.36M
Retained Earnings
-254.73M -199.59M -99.67M -75.21M
Comprehensive Income
-1.42M -1.02M -1.02M -2.18M
Shareholders Equity
272.61M 72.49M -76.61M -53.44M
Total Investments
124.86M 146K 131.53M 129.67M